{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:02:35Z","timestamp":1763499755255,"version":"3.44.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.rvsc.2022.06.033","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T17:30:53Z","timestamp":1658597453000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pharmacokinetics of tildipirosin in horses after intravenous and intramuscular administration and its potential muscle damage"],"prefix":"10.1016","volume":"152","author":[{"given":"Juan Sebastian","family":"Galecio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Badillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2022.06.033_bb0005","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jvp.12958","article-title":"Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses","volume":"44","author":"Abu-Basha","year":"2021","journal-title":"J. Vet. Pharmacol. Therap."},{"issue":"4","key":"10.1016\/j.rvsc.2022.06.033_bb0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2885.2004.00586.x","article-title":"Pharmacokinetics and lung tissue concentrations of tulathromycin in swine","volume":"27","author":"Benchaoui","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2885.2011.01292.x","article-title":"Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals","volume":"35","author":"Berghaus","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/jvp.12402","article-title":"Pharmacokinetics and pulmonary distribution of gamithromycin after intravenous administration in foals","volume":"40","author":"Berlin","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.rvsc.2022.06.033_bb0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2885.2002.00387.x","article-title":"Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes","volume":"25","author":"Davis","year":"2002","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.rvsc.2022.06.033_bb0030","first-page":"8234","article-title":"Tildipirosin may cause cardiotoxicity in sheep","volume":"28","author":"Dik","year":"2017","journal-title":"Biomed. Res."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0035","series-title":"Second Edition","first-page":"169","article-title":"Pharmacologic principles","author":"Dowling","year":"2004"},{"issue":"1","key":"10.1016\/j.rvsc.2022.06.033_bb0040","first-page":"5","article-title":"Pharmacokinetics and bioavailability of tildipirosin in goats using HPLC","volume":"68","author":"Elazab","year":"2020","journal-title":"Jpn. J. Vet. Res."},{"author":"EMA","key":"10.1016\/j.rvsc.2022.06.033_bb0045"},{"year":"2010","series-title":"European public MRL assessment report (EPMAR), Tildipirosin (bovine, porcine and caprine species)","author":"EMEA","key":"10.1016\/j.rvsc.2022.06.033_bb0050"},{"year":"2011","series-title":"CVMP assessment report Zuprevo (EMEA\/V\/C\/002009). London: European Medicines Agency. Report No. EMA\/197236\/2011","author":"EMEA","key":"10.1016\/j.rvsc.2022.06.033_bb0055"},{"key":"10.1016\/j.rvsc.2022.06.033_bb0060","first-page":"1","article-title":"Bioanalytical method validation guidance","volume":"1043","author":"FDA","year":"2018","journal-title":"Food Drug Adm."},{"issue":"8","key":"10.1016\/j.rvsc.2022.06.033_bb0065","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/ani10081332","article-title":"Pharmacokinetics of tildipirosin in ewes after intravenous, intramuscular and subcutaneous administration","volume":"10","author":"Galecio","year":"2020","journal-title":"Animals"},{"issue":"1","key":"10.1016\/j.rvsc.2022.06.033_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2478\/acve-2022-0008","article-title":"Development and validation of an improved HPLC-UV method for the determination of tildipirosin in horse plasma","volume":"72","author":"Galecio","year":"2022","journal-title":"Acta Vet-Beogr."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0075","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/pharmaceutics14040860","article-title":"Pharmacokinetics of tildipirosin in plasma, milk, and somatic cells following intravenous, intramuscular, and subcutaneous administration in dairy goats","volume":"14","author":"Galecio","year":"2022","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.rvsc.2022.06.033_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cveq.2016.11.002","article-title":"Treatment of infections caused by Rhodococcus equi","volume":"33","author":"Gigu\u00e8re","year":"2017","journal-title":"Vet. Clin. Equine Pract."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2885.2009.01125.x","article-title":"Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity","volume":"33","author":"Huang","year":"2010","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0090","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2460\/ajvr.2001.62.1870","article-title":"Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals","volume":"62","author":"Jacks","year":"2001","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3389\/fphar.2018.00765","article-title":"Optimal regimens and cutoff evaluation of tildipirosin against Pasteurella multocida","volume":"9","author":"Lei","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2885.2011.01349.x","article-title":"Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle)","volume":"35","author":"Menge","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2885.1983.tb00456.x","article-title":"Pharmacokinetics of erythromycin in foals and in adult horses","volume":"6","author":"Prescott","year":"1983","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rvsc.2022.06.033_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cveq.2014.11.002","article-title":"Update on bacterial pneumonia and pleuropneumonia in the adult horse","volume":"31","author":"Reuss","year":"2015","journal-title":"Vet. Clin. North Am. Equine Pract."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2885.2012.01397.x","article-title":"Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae","volume":"36","author":"Rose","year":"2013","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rvsc.2022.06.033_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jvp.12333","article-title":"Standard PK\/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf","volume":"40","author":"Toutain","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jvp.12917","article-title":"The pharmacokinetic\/pharmacodynamic paradigm for antimicrobial drugs in veterinary medicine: recent advances and critical appraisal","volume":"44","author":"Toutain","year":"2021","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00210-009-0481-1","article-title":"Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals","volume":"381","author":"Venner","year":"2010","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvp.12010","article-title":"Pharmacokinetics of macrolides in foals","volume":"36","author":"Villarino","year":"2012","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.rvsc.2022.06.033_bb0140","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/jvp.12453","article-title":"Pharmacokinetics of tildipirosin in beagle dogs","volume":"41","author":"Wang","year":"2018","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0145","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2460\/ajvr.67.10.1681","article-title":"Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals","volume":"67","author":"Womble","year":"2006","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0150","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-2885.2006.00804.x","article-title":"Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens","volume":"29","author":"Womble","year":"2006","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0155","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/jvp.12882","article-title":"Pharmacokinetics and bioavailability of tildipirosin in rabbits following single-dose intravenous and intramuscular administration","volume":"43","author":"Xiong","year":"2020","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.rvsc.2022.06.033_bb0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01117450","article-title":"Application of Akaike\u2019s information criterion (AIC) in the evaluation of linear pharmacokinetic equations","volume":"6","author":"Yamaoka","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528822001965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528822001965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:27:07Z","timestamp":1758515227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528822001965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":32,"alternative-id":["S0034528822001965"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2022.06.033","relation":{},"ISSN":["0034-5288"],"issn-type":[{"type":"print","value":"0034-5288"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of tildipirosin in horses after intravenous and intramuscular administration and its potential muscle damage","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2022.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}